Injectable platelet-rich fibrin as a valid therapeutic option for inactive linear morphea (en coup de saber): report of cases.

J Dermatolog TreatMar 3, 2026 (epub)
Case ReportDermatology

Xuechen Ai, Jun He, Pengfei Song et al.

✦ AI-curated · Sources linked

Case in brief

Two patients with inactive linear morphea in an en coup de saber pattern had band-like, atrophic lesions affecting the frontoparietal area, with facial contour defects and pigmentation. Both received injectable platelet-rich fibrin (i-PRF), an autologous platelet concentrate. The report describes satisfactory aesthetic outcomes in both patients within five injection sessions. Adverse effects were limited to mild pain and transient erythema after injection.

What made this case unusual

The report describes aesthetic improvement with i-PRF in inactive en coup de saber morphea, where pharmacological treatments may not meet patients’ aesthetic expectations.

Diagnostic / clinical pearl

In inactive en coup de saber morphea with residual contour and pigmentation changes, i-PRF was associated with satisfactory aesthetic outcomes in these two cases.

Source

Published in J Dermatolog Treat. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.